arrow
Y

Yvonne Schrage

Netherlands Cancer Institute
H指数:22
被引数:1,651

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: real world data from the largest melanoma centres in the Netherlands

[18F]FDG PET/CT的预测价值及新辅助帕博利珠单抗治疗后哨兵淋巴结反应:来自荷兰最大黑色素瘤中心的真实世界数据

2026-03-240
OAAI
Spatial immunoprofiling of retroperitoneal leiomyosarcomas reveals intratumoral heterogeneity in immune cell infiltration, checkpoint molecule expression, and tertiary lymphoid structures

腹膜后平滑肌肉瘤的空间免疫组化分析揭示了肿瘤内部在免疫细胞浸润、检查点分子表达和三级淋巴结构方面的异质性。

2025-10-130
OAAI
Reconsidering the surgical approach in cutaneous melanoma: does wide local excision after a complete diagnostic excision reduce the risk of recurrence?

重新评估皮肤黑色素瘤的手术方法:在完全诊断性切除后进行广泛局部切除能否降低复发风险?

2025-05-010
PRE
The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial)
EJSO
IF2.9
2024-06-013
OAAI
Current practice in assessment and management of malnutrition in surgical oncology practice - An ESSO-EYSAC snapshot analysis
EJSO
IF2.9
2024-05-011
PRE
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma

干扰素-γ 签名作为宏观III期黑色素瘤的预后和预测标志物

2024-04-272
OAAI
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GISTs) is Effective and Safe: Results from a Prospective Single-Center Study with 108 Patients
2023-10-097
PRE
Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study
2023-09-011
OAAI